BioCurex, Inc., a development stage company, engages in developing, producing, marketing, and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It develops various product candidates based on RECAF technology. The company offers its RECAF technology in three basic formats, including automated testing in large clinical and hospital laboratories; non-automated or manual testing by clinicians in smaller laboratory settings; and point-of-care rapid test formats for physicians offices, and urgent care facilities. It also develops RECAF marker, a cancer marker, which is used in blood tests to detect the presence of cancer in humans and animals. The company was formerly known as Whispering Oaks International, Inc. and changed its name to Biocurex, Inc. in October 2009. Biocurex, Inc. was incorporated in 1997 and is based in Richmond, Canada.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for BOCX